These results suggest that Gdpd3-mediated lysophospholipid metabolism may maintain the self-renewal capacity of CML stem cells by activating the stemness factors Foxo3a and β-catenin [14,15]. The gene discussed is GDPD3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.